Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...

The findings revealed a potential link between the use of these drugs and an increased risk of Parkinson’s disease. The risk ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of ...

Some Diabetes Drugs Tied to Lower Risk of Dementia ... brain activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD) ... What the Trained Eye Cannot ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

The blood–brain barrier is a highly selective shield that protects the brain from harmful substances in the bloodstream.

Safe and Precise: Offers non-invasive, targeted treatment with high spatiotemporal precision and excellent biosafety. Parkinson’s disease (PD) is the second most common neurodegenerative disorder, ...